140 related articles for article (PubMed ID: 35093793)
1. Efficacy and Safety of Repetitive Intravenous Sodium Valproate in Pediatric Patients With Refractory Chronic Headache Disorders: A Retrospective Review.
Pavitt S; Gelfand AA; Zorrilla N; Allen I; Riggins N
Pediatr Neurol; 2022 Mar; 128():52-57. PubMed ID: 35093793
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Chart Review of Intravenous Valproate Sodium as a Preventive Treatment for Patients With Chronic Migraine.
Riggins N; Ehrlich A; Sawhney H; Dapkus L; Levin M
Headache; 2020 Mar; 60(3):617-620. PubMed ID: 31985052
[TBL] [Abstract][Full Text] [Related]
3. Intravenous valproate sodium in the treatment of daily headache.
Schwartz TH; Karpitskiy VV; Sohn RS
Headache; 2002 Jun; 42(6):519-22. PubMed ID: 12167141
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
Stillman MJ; Zajac D; Rybicki LA
Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
[TBL] [Abstract][Full Text] [Related]
5. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Sodium Valproate for Acute Pediatric Headache.
Sheridan D; Sun B; O'Brien P; Hansen M
J Emerg Med; 2015 Oct; 49(4):541-5. PubMed ID: 25986331
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine.
Reiter PD; Nickisch J; Merritt G
Headache; 2005; 45(7):899-903. PubMed ID: 15985107
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
[TBL] [Abstract][Full Text] [Related]
12. Intravenous sodium valproate aborts migraine headaches rapidly.
Shahien R; Saleh SA; Bowirrat A
Acta Neurol Scand; 2011 Apr; 123(4):257-65. PubMed ID: 20569223
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
Edwards KR; Norton J; Behnke M
Headache; 2001; 41(10):976-80. PubMed ID: 11903525
[TBL] [Abstract][Full Text] [Related]
14. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
[TBL] [Abstract][Full Text] [Related]
15. Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache.
Nelson GR; Bale JF; Kerr LM
Pediatr Neurol; 2017 Jan; 66():76-81. PubMed ID: 27847180
[TBL] [Abstract][Full Text] [Related]
16. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.
Mathew NT; Kailasam J; Meadors L; Chernyschev O; Gentry P
Headache; 2000 Oct; 40(9):720-3. PubMed ID: 11091289
[TBL] [Abstract][Full Text] [Related]
17. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
Caruso JM; Brown WD; Exil G; Gascon GG
Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks.
Leniger T; Pageler L; Stude P; Diener HC; Limmroth V
Headache; 2005 Jan; 45(1):42-6. PubMed ID: 15663612
[TBL] [Abstract][Full Text] [Related]
20. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
Coskun O; Ucler S; Cavdar L; Inan LE
J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
